These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Phase II evaluation of maytansine (NSC 153858) in advanced cancer. A Southeastern Cancer Study Group trial.
    Author: Ravry MJ, Omura GA, Birch R.
    Journal: Am J Clin Oncol; 1985 Apr; 8(2):148-50. PubMed ID: 3834790.
    Abstract:
    Maytansine given in a 3-day course q3 weeks produced only five responses (3%) in 163 evaluable adults with advanced cancer. The dose schedule employed is not recommended for further study.
    [Abstract] [Full Text] [Related] [New Search]